Hong Kong Pharma Digital Technology Holdings Ltd
HKPD
Competitive advantage analysis ·
healthcare
Corporate Default
Overall moat score
36/100
Developing
WeakDevelopingModeratepeer medianStrong
About Hong Kong Pharma Digital Technology Holdings Ltd
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. …
Full HKPD analysis →
Competitive advantage assessment
Key strengths
Strong Liquidity BufferLiquidity position is strong (score 0.91), providing operational cushion.
Key risks
ROIC Below WACC or PeersROIC at 39.7th percentile suggests inefficient capital deployment.
Where HKPD ranks in Healthcare: Providers, Plans & Distribution
Hong Kong Pharma Digital Technology Holdings Ltd ranks #96 of 156
scored companies in Healthcare: Providers, Plans & Distribution by moat score — the top 62%.
The widest moat in the group is Veeva Systems Inc. (VEEV)
at 88/100.
Moat scores for companies ranked near HKPD in Healthcare: Providers, Plans & Distribution
Pricing power is the ability to raise prices without losing volume.
Cost Advantage
Score 55
· 15% of the moat score
A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.
Customer Stickiness
Score 29
· 15% of the moat score
Stickiness is what makes revenue repeat without being re-won every year.
Capital Efficiency
Score 27
· 18% of the moat score
Capital efficiency asks what the company earns on the money tied up in the business.
Resilience
Score 53
· 17% of the moat score
Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.
Scale & Market Position
Score 24
· 15% of the moat score
Scale matters only when it converts into economics.
What is Hong Kong Pharma Digital Technology Holdings Ltd's moat score?
Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) scores 36 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as developing. It ranks #96 of 156 scored companies in Healthcare: Providers, Plans & Distribution, the top 62%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 155 companies in Healthcare: Providers, Plans & Distribution. Its strongest defense is Cost Advantage (55/100) and its weakest is Scale & Market Position (24/100).
How does Hong Kong Pharma Digital Technology Holdings Ltd compare with other Healthcare: Providers, Plans & Distribution companies?
Hong Kong Pharma Digital Technology Holdings Ltd ranks #96 of 156 scored companies in Healthcare: Providers, Plans & Distribution by moat score. The widest moat in Healthcare: Providers, Plans & Distribution is Veeva Systems Inc. (VEEV) at 88/100. The companies ranked closest are American Oncology Network, Inc. (AONC) at 36 just above it and American Oncology Network, Inc. (AONCW) at 36 just below it.
How is the moat score calculated?
Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 155 companies in Healthcare: Providers, Plans & Distribution. The defenses are then weighted to produce the overall score out of 100.
Why is Hong Kong Pharma Digital Technology Holdings Ltd scored with the Corporate Default template?
Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.
Which competitive defenses are measured for Hong Kong Pharma Digital Technology Holdings Ltd?
The Corporate Default template measures 6 defenses, and HKPD scores: Pricing Power (31), Cost Advantage (55), Customer Stickiness (29), Capital Efficiency (27), Resilience (53), Scale & Market Position (24). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.
We value your privacy
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking 'Accept All', you consent to our use of cookies.
Read our cookie policy
Cookie Preferences
Manage your cookie preferences. Essential cookies are always enabled.